64 reports

  • GENETIC DISORDERS, COMMON SYMPTOMS OF GENETIC DISORDERS
  • GENETIC DISORDERS, PROGRESSION OF CF
  • Genetic Disorder
  • World
  • Market Size
  • Alexion Pharmaceuticals, Inc.
  • Alnylam Pharmaceuticals, Inc.

Genetic Disorders royalty rates Chapter ## – Leading Genetic Disorders deals and dealmakers ##. ##.

  • Genetic Disorder
  • Pathology
  • World
  • JAPAN - CYSTIC FIBROSIS THERAPEUTICS MARKET (MILLION US$), 2014 - 2016
  • 6.2 CANADA CYSTIC FIBROSIS THERAPEUTICS MARKET & FORECAST
  • Genetic Disorder
  • World
  • Market Size
  • AbbVie Inc.
  • Editas Medicine, Inc.
  • Proportion of Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) to Genetic Disorders
  • Proportion of Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) to Genetic Disorders
  • Genetic Disorder
  • World
  • Aldagen, Inc.
  • Asklepion Pharmaceuticals, LLC
  • Nutra Pharma Corporation
  • Key Trends
  • 5.2.2.4.4.4 REST OF MENA
  • Genetic Disorder
  • World
  • Forecast
  • Biocartis S.A.
  • Transgenomic, Inc.
  • Clinical Trials by G7 Countries: Proportion of Primary Immune Deficiency (PID) to Genetic Disorders Clinical Trials
  • Clinical Trials by E7 Countries: Proportion of Primary Immune Deficiency (PID) to Genetic Disorders Clinical Trials
  • Genetic Disorder
  • World
  • Baxter International Inc.
  • Biotest AG
  • CSL Limited

Genetic Influences on Cystic Fibrosis Lung Disease Severity.

  • Genetic Disorder
  • World
  • Market Size
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • PULMONARY HYPERTENSION

Engages in the development of drugs in areas such as immuno-oncology, oncology, immunoscience, virology, cardiovascular, fibrotic diseases, and metabolic and genetically defined diseases.

  • Genetic Disorder
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG

Genetic Disorders, Infectious Diseases, Musculoskeletal Disorders, Neurologic Disorders, Respiratory Disorders, Skin Diseases, Transplantation, and Others.............. ## Table ##: Injectables Market by Segment Worldwide (2015) - Percentage Share Breakdow

  • Genetic Disorder
  • Pharmaceutical
  • China
  • World
  • Demand

Cystic fibrosis and bone disease: are we missing a genetic link?

  • Genetic Disorder
  • Mortality
  • Canada
  • Italy
  • Forecast
  • Snapshot of Cystic Fibrosis
  • 06. Introduction
  • Genetic Disorder
  • Europe
  • Actavis plc
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.

Cystic fibrosis and bone disease: are we missing a genetic link?

  • Genetic Disorder
  • Forest Laboratories, Inc.
  • Novartis AG
  • Pharmaxis Ltd
  • Vertex Pharmaceuticals Incorporated
  • PREVALENCE OF GENETIC DISORDERS (2012)
  • 8.2 GENETIC DISORDERS
  • Cytogenetic
  • Genetic Disorder
  • World
  • Market Size
  • Agilent Technologies, Inc.
  • PROPORTION OF DOWN SYNDROME TO GENETIC DISORDERS CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • PROPORTION OF DOWN SYNDROME TO GENETIC DISORDERS CLINICAL TRIALS, E7 COUNTRIES (%), 2017*
  • Genetic Disorder
  • Therapy
  • World
  • Product Initiative
  • F. Hoffmann-La Roche Ltd.
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF FABRY DISEASE TO GENETIC DISORDERS CLINICAL TRIALS
  • CLINICAL TRIALS BY E7 COUNTRIES: PROPORTION OF FABRY DISEASE TO GENETIC DISORDERS CLINICAL TRIALS
  • Clinical Trial
  • Drug Discovery And Development
  • Genetic Disorder
  • World
  • Product Initiative
  • PROPORTION OF GAUCHER DISEASE TO GENETIC DISORDERS CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • PROPORTION OF GAUCHER DISEASE TO GENETIC DISORDERS CLINICAL TRIALS, E7 COUNTRIES (%), 2017*
  • Biopharmaceutical
  • Genetic Disorder
  • Pathology
  • World
  • Product Initiative
  • PROPORTION OF FRAGILE X SYNDROME TO GENETIC DISORDERS CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF FRAGILE X SYNDROME TO GENETIC DISORDERS CLINICAL TRIALS
  • Genetic Disorder
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative
  • PROPORTION OF MUCKLE-WELLS SYNDROME TO GENETIC DISORDERS CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • Proportion of Muckle-Wells Syndrome to Genetic Disorders Clinical Trials, G7 Countries (%), 2016*
  • Genetic Disorder
  • Therapy
  • World
  • Product Initiative
  • Novartis AG
  • PROPORTION OF DUCHENNE MUSCULAR DYSTROPHY TO GENETIC DISORDERS CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • PROPORTION OF DUCHENNE MUSCULAR DYSTROPHY TO GENETIC DISORDERS CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • Genetic Disorder
  • Therapy
  • World
  • Product Initiative
  • Sarepta Therapeutics, Inc.
  • PROPORTION OF LYSOSOMAL STORAGE DISORDER TO GENETIC DISORDERS CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • CLINICAL TRIALS BY E7 COUNTRIES: PROPORTION OF LYSOSOMAL STORAGE DISORDER TO GENETIC DISORDERS CLINICAL TRIALS
  • Clinical Trial
  • Drug Discovery And Development
  • Genetic Disorder
  • World
  • Product Initiative
  • PROPORTION OF BECKER MUSCULAR DYSTROPHY TO GENETIC DISORDERS CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • Clinical Trials by G7 Countries: Proportion of Becker Muscular Dystrophy to Genetic Disorders Clinical Trials
  • Genetic Disorder
  • Mental Health
  • Neurological Disorder
  • World
  • Product Initiative
  • PROPORTION OF ALPHA- ANTITRYPSIN DEFICIENCY TO GENETIC DISORDERS CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • PROPORTION OF ALPHA- ANTITRYPSIN DEFICIENCY TO GENETIC DISORDERS CLINICAL TRIALS, E7 COUNTRIES (%), 2017*
  • Antiviral
  • Genetic Disorder
  • World
  • Product Initiative
  • Grifols, S.A.
  • PROPORTION OF ALPHA-MANNOSIDOSIS TO GENETIC DISORDERS CLINICAL TRIALS, E7 COUNTRIES (%), 2017*
  • PROPORTION OF ALPHA-MANNOSIDOSIS TO GENETIC DISORDERS CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • Genetic Disorder
  • Neurological Disorder
  • Therapy
  • World
  • Product Initiative
  • Clinical Trials by G7 Countries: Proportion of Polycystic Kidney Disease to Genetic Disorders Clinical Trials
  • Clinical Trials by E7 Countries: Proportion of Polycystic Kidney Disease to Genetic Disorders Clinical Trials
  • Genetic Disorder
  • Pharmaceutical
  • World
  • Product Initiative
  • Otsuka Pharmaceutical Co., Ltd.
  • PROPORTION OF CHEDIAK-HIGASHI SYNDROME TO GENETIC DISORDERS CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF CHEDIAK-HIGASHI SYNDROME TO GENETIC DISORDERS CLINICAL TRIALS
  • Blood Disease
  • Genetic Disorder
  • Monoclonal Antibody
  • World
  • Miltenyi Biotec GmbH
  • Proportion of Becker Muscular Dystrophy to Genetic Disorders Clinical Trials, G7 Countries (%), 2016*
  • Clinical Trials by E7 Countries: Proportion of Becker Muscular Dystrophy to Genetic Disorders Clinical Trials
  • Genetic Disorder
  • Neurological Disorder
  • World
  • Product Initiative
  • PTC Therapeutics, Inc.
  • Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials, G7 Countries (%), 2016*
  • Clinical Trials by E7 Countries: Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials
  • Genetic Disorder
  • Hepatitis Treatment
  • World
  • Product Initiative
  • Grifols, S.A.
  • Proportion of Tay-Sachs Disease to Genetic Disorders Clinical Trials, G7 Countries (%), 2016*
  • Clinical Trials by G7 Countries: Proportion of Tay-Sachs Disease to Genetic Disorders Clinical Trials
  • Genetic Disorder
  • Mental Health
  • Neurological Disorder
  • World
  • Product Initiative
  • Proportion of Tuberous Sclerosis to Genetic Disorders Clinical Trials, G7 Countries (%), 2016*
  • Proportion of Tuberous Sclerosis to Genetic Disorders Clinical Trials, E7 Countries (%), 2016*
  • Anti-Infective
  • Genetic Disorder
  • World
  • Product Initiative
  • Novartis AG
  • GENETIC DISORDERS IN NEWBORNS
  • 3.3.1. CLASSIFICATION OF GENETIC DISORDERS
  • Chromosome
  • Genetic
  • Genetic Disorder
  • World
  • Company